Gennex Laboratories Ltd

Gennex Lab. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Gennex Laboratories Ltd

₹ 15.6 1.23%
03 Jul 9:09 a.m.
gennexlab.com BSE: 531739
About

Incorporated in 1995, Gennex Laboratories Ltd manufactures Bulk Drugs and Intermediaries[1]

Key Points

Business Overview:[1][2]
GLL is an ISO 9001:2008, TUV, ISO 14001 and OSHAS 18000 certified vertically integrated Active Pharmaceutical Ingredient manufacturer & exporter of Bulk Drugs, Intermediates and Biotech Products in the form of Expectorants,
Muscle Relaxants, Analgesic and Anti Fungal, etc.

Website BSE
  • Market Cap ₹ 356 Cr.
  • Current Price ₹ 15.6
  • High / Low ₹ 21.9 / 6.12
  • Stock P/E 27.0
  • Book Value ₹ 7.49
  • Dividend Yield 0.00 %
  • ROCE 13.8 %
  • ROE 10.5 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company is expected to give good quarter
  • Company has delivered good profit growth of 42.8% CAGR over last 5 years

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding has decreased over last quarter: -5.18%
  • Promoter holding is low: 18.4%
  • Company has a low return on equity of 9.59% over last 3 years.
  • Working capital days have increased from 147 days to 264 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
16.21 10.40 14.29 16.69 21.22 14.51 19.62 14.63 20.80 16.52 18.18 21.39 35.52
13.65 8.75 12.34 15.36 19.39 13.06 17.76 12.81 17.28 11.42 12.41 16.59 29.26
Operating Profit 2.56 1.65 1.95 1.33 1.83 1.45 1.86 1.82 3.52 5.10 5.77 4.80 6.26
OPM % 15.79% 15.87% 13.65% 7.97% 8.62% 9.99% 9.48% 12.44% 16.92% 30.87% 31.74% 22.44% 17.62%
0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.21 0.15 0.24 0.14 0.20 0.26 0.10 0.19 0.63 0.73 0.78 0.83 0.73
Depreciation 0.22 0.20 0.20 0.19 0.34 0.18 0.36 0.18 0.37 0.65 1.03 0.45 0.23
Profit before tax 2.15 1.30 1.51 1.00 1.29 1.01 1.40 1.45 2.52 3.72 3.96 3.52 5.30
Tax % 8.84% 26.92% 26.49% 21.00% 16.28% 24.75% 25.00% 24.83% 19.05% 23.39% 22.47% 21.31% 15.28%
1.95 0.95 1.11 0.79 1.07 0.75 1.05 1.08 2.04 2.85 3.07 2.76 4.50
EPS in Rs 0.10 0.05 0.06 0.04 0.06 0.04 0.06 0.07 0.12 0.16 0.17 0.16 0.20
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
42 44 56 56 60 61 66 92
37 42 52 52 53 56 61 70
Operating Profit 5 2 4 3 7 5 5 22
OPM % 11% 5% 7% 6% 11% 9% 7% 24%
0 1 1 1 0 1 4 0
Interest 1 1 1 1 1 1 1 3
Depreciation 1 1 1 1 1 1 1 2
Profit before tax 3 1 3 3 5 5 6 16
Tax % 13% 42% 26% 27% 20% 23% 23% 20%
3 1 2 2 4 4 5 13
EPS in Rs 0.14 0.04 0.12 0.10 0.21 0.21 0.28 0.58
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 10%
3 Years: 15%
TTM: 40%
Compounded Profit Growth
10 Years: %
5 Years: 43%
3 Years: 45%
TTM: 170%
Stock Price CAGR
10 Years: 28%
5 Years: 36%
3 Years: 17%
1 Year: 130%
Return on Equity
10 Years: %
5 Years: 9%
3 Years: 10%
Last Year: 11%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 13 13 13 13 13 13 18 23
Reserves 18 19 21 23 27 31 62 148
4 2 5 5 7 10 1 19
14 16 13 16 12 14 51 41
Total Liabilities 49 50 52 57 59 68 132 230
16 16 16 15 14 14 83 65
CWIP 0 0 0 0 0 0 0 2
Investments 7 7 7 7 7 7 0 0
26 28 29 35 38 48 49 163
Total Assets 49 50 52 57 59 68 132 230

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
-0 3 2 -2 -1 12 24 -47
-1 -1 -1 -0 -0 -2 -38 19
1 -2 1 -0 2 -2 21 74
Net Cash Flow -0 0 2 -2 0 8 6 46

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 90 87 68 41 55 67 52 71
Inventory Days 43 31 57 78 50 72 139 188
Days Payable 139 161 88 86 59 72 63 113
Cash Conversion Cycle -7 -43 38 34 46 67 129 146
Working Capital Days 106 93 86 119 153 148 29 264
ROCE % 6% 11% 8% 14% 12% 11%

Shareholding Pattern

Numbers in percentages

5 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
22.05% 22.05% 22.05% 22.05% 22.05% 23.38% 23.38% 23.38% 23.38% 23.61% 23.61% 18.41%
77.95% 77.95% 77.95% 77.95% 77.95% 76.63% 76.62% 76.62% 76.62% 76.39% 76.39% 81.58%
No. of Shareholders 36,24346,38050,05256,68957,87759,17258,24855,60952,98150,98869,72383,996

Documents

Announcements

Annual reports

Right Issue